Ignite Creation Date:
2024-05-06 @ 2:01 PM
Last Modification Date:
2024-10-26 @ 1:23 PM
Study NCT ID:
NCT04191499
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2019-12-02
Brief Title:
A Study Evaluating the Efficacy and Safety of Inavolisib Palbociclib Fulvestrant vs Placebo Palbociclib Fulvestrant in Patients With PIK3CA-Mutant Hormone Receptor-Positive Her2-Negative Locally Advanced or Metastatic Breast Cancer
Sponsor:
Organization:
Hoffmann-La Roche